par Lohmann, Ana Elisa;Saini, Kamal 
;Metzger-Filho, Otto
Référence Translational lung cancer research, 1, 2, page (122-124)
Publication Publié, 2012-08
;Metzger-Filho, OttoRéférence Translational lung cancer research, 1, 2, page (122-124)
Publication Publié, 2012-08
Article révisé par les pairs
| Résumé : | Recently, Baselga and colleagues published in New England Journal of Medicine the analyses of the Clinical Evaluation of Pertuzumab and Trastuzumab Study (CLEOPATRA). CLEOPATRA is a phase III trial in 808 patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer receiving first line therapy with docetaxel and trastuzumab with placebo or pertuzumab until disease progression or unacceptable toxicity. |
